Makers Laboratories Ltd banner
M

Makers Laboratories Ltd
BSE:506919

Watchlist Manager
Makers Laboratories Ltd
BSE:506919
Watchlist
Price: 124.5 INR -1.58% Market Closed
Market Cap: ₹734.6m

Relative Value

506919 doesn't have a meaningful market cap.

The Relative Value of one MAKERSL stock under the Base Case scenario is hidden INR. Compared to the current market price of 124.5 INR, Makers Laboratories Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MAKERSL Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

MAKERSL Competitors Multiples
Makers Laboratories Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Makers Laboratories Ltd
BSE:506919
734.6m INR 0.6 -3 369.7 7.2 13.2
US
Eli Lilly and Co
NYSE:LLY
964.4B USD 14.8 46.7 31.5 33.5
US
Johnson & Johnson
NYSE:JNJ
572.6B USD 6.1 21.4 14.9 18.2
CH
Roche Holding AG
SIX:ROG
282.5B CHF 4.6 30.3 12.8 14.9
US
Merck & Co Inc
NYSE:MRK
297.7B USD 4.6 16.3 10.2 11.9
CH
Novartis AG
SIX:NOVN
227.6B CHF 5.2 21 13 16.7
UK
AstraZeneca PLC
LSE:AZN
215.5B GBP 5.2 32.1 15.3 22.4
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.2 12.8 9.4 11
US
Pfizer Inc
NYSE:PFE
151.1B USD 2.4 19.4 7.3 9.7
US
Bristol-Myers Squibb Co
NYSE:BMY
120.9B USD 2.5 20 7.1 9.3
P/E Multiple
Earnings Growth PEG
IN
M
Makers Laboratories Ltd
BSE:506919
Average P/E: 24.5
Negative Multiple: -3 369.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
46.7
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
21.4
6%
3.6
CH
Roche Holding AG
SIX:ROG
30.3
29%
1
US
Merck & Co Inc
NYSE:MRK
16.3
14%
1.2
CH
Novartis AG
SIX:NOVN
21
15%
1.4
UK
AstraZeneca PLC
LSE:AZN
32.1
38%
0.8
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
7%
1.8
US
Pfizer Inc
NYSE:PFE
19.4
26%
0.7
US
Bristol-Myers Squibb Co
NYSE:BMY
20
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
M
Makers Laboratories Ltd
BSE:506919
Average EV/EBITDA: 42
7.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
31.5
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
14.9
2%
7.4
CH
Roche Holding AG
SIX:ROG
12.8
5%
2.6
US
Merck & Co Inc
NYSE:MRK
10.2
7%
1.5
CH
Novartis AG
SIX:NOVN
13
9%
1.4
UK
AstraZeneca PLC
LSE:AZN
15.3
10%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.4
7%
1.3
US
Pfizer Inc
NYSE:PFE
7.3
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.1
-9%
N/A